Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -25.426% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCCCN1C[C@H](Cc2ccccc2)[C@@H](CC(=O)Nc2ccccc2)C1=O
b) CCc1ccc(N(C(=O)c2csnn2)C(C(=O)NCc2ccccc2)c2ccco2)cc1
Answer: a. CCCCN1C[C@H](Cc2ccccc2)[C@@H](CC(=O)Nc2ccccc2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN1C[C@H](Cc2ccccc2)[C@@H](CC(=O)Nc2ccccc2)C1=O
CCCCN1C[C@H](Cc2ccccc2)[C@@H](CC(=O)Nc2ccccc2)C1=O
2-[(3R,4R)-4-benzyl-1-butyl-2-oxopyrrolidin-3-yl]-N-phenylacetamide